Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126879141 | 12687914 | 1 | I | 20160817 | 20160826 | 20160826 | EXP | CA-PFIZER INC-2016400615 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160826 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126879141 | 12687914 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | U | 0 | ||||||||||
| 126879141 | 12687914 | 2 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | U | 203214 | 5 | MG | TABLET | BID | |||||
| 126879141 | 12687914 | 3 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 400 MG, UNK | U | 0 | 400 | MG | ||||||||
| 126879141 | 12687914 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 5 MG, 2X/DAY | U | 0 | 5 | MG | TABLET | BID | |||||
| 126879141 | 12687914 | 5 | SS | NAPROXEN. | NAPROXEN | 1 | UNK | U | 0 | ||||||||||
| 126879141 | 12687914 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 126879141 | 12687914 | 7 | C | ACTEMRA | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 126879141 | 12687914 | 8 | C | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 126879141 | 12687914 | 9 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | 0 | |||||||||||
| 126879141 | 12687914 | 10 | C | ORENCIA | ABATACEPT | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126879141 | 12687914 | 1 | Rheumatoid arthritis |
| 126879141 | 12687914 | 2 | Rheumatoid arthritis |
| 126879141 | 12687914 | 3 | Rheumatoid arthritis |
| 126879141 | 12687914 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126879141 | 12687914 | OT |
| 126879141 | 12687914 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126879141 | 12687914 | Arthropathy | |
| 126879141 | 12687914 | Bone disorder | |
| 126879141 | 12687914 | C-reactive protein abnormal | |
| 126879141 | 12687914 | Fall | |
| 126879141 | 12687914 | Fatigue | |
| 126879141 | 12687914 | Femur fracture | |
| 126879141 | 12687914 | Osteoporosis | |
| 126879141 | 12687914 | Pain | |
| 126879141 | 12687914 | Rash | |
| 126879141 | 12687914 | Red blood cell sedimentation rate abnormal | |
| 126879141 | 12687914 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |